babbuino68
Forumer attivo
Che legnate. Di nuovo quasi rossi. E' una giostra oggi
Certificati di investimento - Cap. 2 (8 lettori)
- Creatore Discussione giancarlo22
- Data di Inizio
- Stato
Eattheapple
Forumer storico
Venduto CH0372885993 @ 951,5
attilioteo
Forumer attivo
Sold XS1314819266
genoalè
Forumer storico
Mi sembra presto. Aspettiamo stm sotto i 12 e poi vediamo
io ho questo reverse e penso di tenerlo: DE000HV42WJ3
CarloConti
Forumer storico
Giornata in generale comunque positiva. Importante procedere in questa direzione. Negli ultimi tempi, secondo me generalmente positivi, una delle poche note negative è stato quel -6% di telecom del 12 marzo che ha fatto perdere quel recupero fatto. Spero che Telecom venerdì si rifaccia di quella giornata, ma la vedo dura.
Luca_niubbo
Forumer storico
XS1684040774 quota 79. E' vero che il rimborso quest'anno mi sembra molto improbabile...
qua DE000HV42WJ3 c'è barriera continua. E' anche vero che mancano meno di 6 mesi e c'è quasi un 10% di gain se ho capito bene..
NoWay
It's time to play the game
Comprandolo non ho pensato ad un rimborso anticipato, ma il calo di oggi di Stm mi è sembrato eccessivo. Questo certificato garantisce una cedola incondizionata a dicembre e c'è ancora un po' di margine sulla barriera (che comunque "conta" solo nel 2021). Ciò non toglie che, se ci fosse un rimbalzo, prenderei profitto nel breve.
Fabrib
Forumer storico
A jury Wednesday awarded $80.3 million in damages to a California resident the jurors found contracted cancer from exposure to Bayer AG's Roundup weedkillers.
The San Francisco jury's finding that Monsanto Co. -- now owned by German chemicals and pharmaceuticals giant Bayer -- acted negligently in failing to adequately warn about Roundup's danger is the latest setback in Bayer's efforts to clear its products of allegations that they trigger non-Hodgkin lymphoma and other cancers.
Analysts had widely expected the jury to hold Bayer liable for Edwin Hardeman's cancer in this two-phase federal court trial after the six-person jury in the first phase already reached the conclusion that Roundup was largely to blame for his illness.
While the first phase focused on scientific evidence to determine whether a link exists between Roundup and Mr. Hardeman's non-Hodgkin lymphoma, the jury in the second phase was to determine Monsanto's liability.
"Bayer stands behind these products and will vigorously defend them," the company said after the verdict, adding that it plans to appeal and that Wednesday's verdict has no effect on future trials. Attorneys for the plaintiff said the jury "sent a message to Monsanto that it needs to change the way it does business."
Reuters
The San Francisco jury's finding that Monsanto Co. -- now owned by German chemicals and pharmaceuticals giant Bayer -- acted negligently in failing to adequately warn about Roundup's danger is the latest setback in Bayer's efforts to clear its products of allegations that they trigger non-Hodgkin lymphoma and other cancers.
Analysts had widely expected the jury to hold Bayer liable for Edwin Hardeman's cancer in this two-phase federal court trial after the six-person jury in the first phase already reached the conclusion that Roundup was largely to blame for his illness.
While the first phase focused on scientific evidence to determine whether a link exists between Roundup and Mr. Hardeman's non-Hodgkin lymphoma, the jury in the second phase was to determine Monsanto's liability.
"Bayer stands behind these products and will vigorously defend them," the company said after the verdict, adding that it plans to appeal and that Wednesday's verdict has no effect on future trials. Attorneys for the plaintiff said the jury "sent a message to Monsanto that it needs to change the way it does business."
Reuters
- Stato